News
Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates
Entrada Therapeutics, Inc. (TRDA) came out with a quarterly loss of $1.06 per share versus the Zacks Consensus Estimate of a loss of $1.04. This compares to a loss of $0.35 per share a year ago
Skillz Inc. (SKLZ) Reports Q3 Loss, Misses Revenue Estimates
Skillz Inc. (SKLZ) came out with a quarterly loss of $1.14 per share versus the Zacks Consensus Estimate of a loss of $1.28. This compares to a loss of $1.2 per share a year ago. These figures are
Shift4 Payments (FOUR) Q3 Earnings and Revenues Top Estimates
Shift4 Payments (FOUR) came out with quarterly earnings of $1.47 per share, beating the Zacks Consensus Estimate of $1.46 per share. This compares to earnings of $1.04 per share a year ago. These
Monte Rosa Therapeutics (GLUE) Reports Q3 Loss, Tops Revenue Estimates
Monte Rosa Therapeutics (GLUE) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.29 per share a year ago. These
BlackSky Technology Inc. (BKSY) Reports Q3 Loss, Misses Revenue Estimates
BlackSky Technology Inc. (BKSY) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to a loss of $0.66 per share a year ago. These
Americold Realty Trust Inc. (COLD) Matches Q3 FFO Estimates
Americold Realty Trust Inc. (COLD) came out with quarterly funds from operations (FFO) of $0.35 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.35 per share a year
CyberArk (CYBR) Q3 Earnings and Revenues Top Estimates
CyberArk (CYBR) came out with quarterly earnings of $1.2 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.94 per share a year ago. These figures
Altice USA, Inc. (ATUS) Reports Q3 Loss, Lags Revenue Estimates
Altice USA, Inc. (ATUS) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.09 per share a year ago. These figures
Here's How Much You'd Have If You Invested $1000 in Flex a Decade Ago
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors
Angel Oak Mortgage (AOMR) Lags Q3 Earnings and Revenue Estimates
Angel Oak Mortgage (AOMR) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to a loss of $0.14 per share a year ago. These
Embraer's Q3 Earnings Fall Year Over Year, Revenues Rise
Share price of Embraer S.A. EMBJ rose 4.1% to $64.58 on Nov. 5, following its third-quarter 2025 results.The company reported a third-quarter 2025 adjusted earnings of 30 cents per American
STE Stock Gains on Q2 Earnings and Revenue Beat, '26 EPS View Up
STERIS plc STE reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.47, up 15.4% from the year-ago quarter’s figure. The figure surpassed the Zacks Consensus Estimate by 3.8%.
SolarEdge Technologies Q3 Earnings Top Estimates, Revenues Rise Y/Y
SolarEdge Technologies, Inc. SEDG reported a third-quarter 2025 adjusted loss of 31 cents per share, narrower than the Zacks Consensus Estimate of a loss of 38 cents. The bottom line also improved
Duke Energy to Release Q3 Earnings: Here's What You Need to Know
Duke Energy DUK is scheduled to release third-quarter 2025 results on Nov. 7, before market open. The company delivered an earnings surprise of 5% in the last reported quarter. Let’s discuss the
ADMA's Q3 Earnings Match Estimates, Revenues Beat on Strong Asceniv Sales
ADMA Biologics ADMA reported third-quarter 2025 adjusted earnings per share (EPS) of 16 cents, which were in line with the Zacks Consensus Estimate. In the year-ago quarter, the company reported
Regenxbio (RGNX) Reports Q3 Loss, Beats Revenue Estimates
Regenxbio (RGNX) came out with a quarterly loss of $1.2 per share versus the Zacks Consensus Estimate of a loss of $1.38. This compares to a loss of $1.17 per share a year ago. These figures are
C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Beats Revenue Estimates
C4 Therapeutics, Inc. (CCCC) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to a loss of $0.35 per share a year ago. These
Kimbell Royalty (KRP) Beats Q3 Earnings and Revenue Estimates
Kimbell Royalty (KRP) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.22 per share a year ago. These
Gogo (GOGO) Surpasses Q3 Earnings and Revenue Estimates
Gogo (GOGO) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.12 per share a year ago. These figures are
CMG Comps Under Pressure: Can Menu Innovation Reignite Traffic?
Chipotle Mexican Grill CMG reported third-quarter 2025 results that reflected a softer consumer environment and slowing traffic trends. Comparable sales increased just 0.3%, as lower dining
Warner Bros. Discovery (WBD) Reports Q3 Loss, Misses Revenue Estimates
Warner Bros. Discovery (WBD) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.05 per share a year ago. These
NRG Energy (NRG) Tops Q3 Earnings and Revenue Estimates
NRG Energy (NRG) came out with quarterly earnings of $2.75 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $1.85 per share a year ago. These figures
N-able (NABL) Tops Q3 Earnings and Revenue Estimates
N-able (NABL) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.13 per share a year ago. These figures are
Papa John's (PZZA) Q3 Earnings and Revenues Miss Estimates
Papa John's (PZZA) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.43 per share a year ago. These figures


